世界の未熟児網膜症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retinopathy Of Prematurity Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4829 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、未熟児網膜症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IB-09A0133、メカセルミンリンファベート、プロプラノロール、R-200、その他）、用途別市場規模（病院、クリニック、在宅医療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・未熟児網膜症治療薬の市場動向 ・企業の競争状況、市場シェア ・未熟児網膜症治療薬の種類別市場規模と予測2016-2027（IB-09A0133、メカセルミンリンファベート、プロプラノロール、R-200、その他） ・未熟児網膜症治療薬の用途別市場規模と予測2016-2027（病院、クリニック、在宅医療） ・未熟児網膜症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・未熟児網膜症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・未熟児網膜症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・未熟児網膜症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・未熟児網膜症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biomar Microbial Technologies、D. Western Therapeutics Institute Inc、F. Hoffmann-La Roche Ltd、Insmed Inc、Recordati SpA） ・結論

Market Analysis and Insights: Global Retinopathy Of Prematurity Therapeutics Market
The global Retinopathy Of Prematurity Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinopathy Of Prematurity Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinopathy Of Prematurity Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinopathy Of Prematurity Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinopathy Of Prematurity Therapeutics market.

Global Retinopathy Of Prematurity Therapeutics Scope and Market Size
Retinopathy Of Prematurity Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinopathy Of Prematurity Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
IB-09A0133
Mecasermin Rinfabate
Propranolol
R-200
Others

Segment by Application
Hospital
Clinic
Home Care

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biomar Microbial Technologies
D. Western Therapeutics Institute Inc
F. Hoffmann-La Roche Ltd
Insmed Inc
Recordati SpA

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IB-09A0133
1.2.3 Mecasermin Rinfabate
1.2.4 Propranolol
1.2.5 R-200
1.2.6 Others
1.3 Market by Application
1.3.1 Global Retinopathy Of Prematurity Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinopathy Of Prematurity Therapeutics Market Perspective (2016-2027)
2.2 Retinopathy Of Prematurity Therapeutics Growth Trends by Regions
2.2.1 Retinopathy Of Prematurity Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinopathy Of Prematurity Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Retinopathy Of Prematurity Therapeutics Industry Dynamic
2.3.1 Retinopathy Of Prematurity Therapeutics Market Trends
2.3.2 Retinopathy Of Prematurity Therapeutics Market Drivers
2.3.3 Retinopathy Of Prematurity Therapeutics Market Challenges
2.3.4 Retinopathy Of Prematurity Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinopathy Of Prematurity Therapeutics Players by Revenue
3.1.1 Global Top Retinopathy Of Prematurity Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Retinopathy Of Prematurity Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinopathy Of Prematurity Therapeutics Revenue
3.4 Global Retinopathy Of Prematurity Therapeutics Market Concentration Ratio
3.4.1 Global Retinopathy Of Prematurity Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinopathy Of Prematurity Therapeutics Revenue in 2020
3.5 Retinopathy Of Prematurity Therapeutics Key Players Head office and Area Served
3.6 Key Players Retinopathy Of Prematurity Therapeutics Product Solution and Service
3.7 Date of Enter into Retinopathy Of Prematurity Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinopathy Of Prematurity Therapeutics Breakdown Data by Type
4.1 Global Retinopathy Of Prematurity Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Type (2022-2027)

5 Retinopathy Of Prematurity Therapeutics Breakdown Data by Application
5.1 Global Retinopathy Of Prematurity Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinopathy Of Prematurity Therapeutics Market Size (2016-2027)
6.2 North America Retinopathy Of Prematurity Therapeutics Market Size by Type
6.2.1 North America Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2027)
6.3 North America Retinopathy Of Prematurity Therapeutics Market Size by Application
6.3.1 North America Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2027)
6.4 North America Retinopathy Of Prematurity Therapeutics Market Size by Country
6.4.1 North America Retinopathy Of Prematurity Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Retinopathy Of Prematurity Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retinopathy Of Prematurity Therapeutics Market Size (2016-2027)
7.2 Europe Retinopathy Of Prematurity Therapeutics Market Size by Type
7.2.1 Europe Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2027)
7.3 Europe Retinopathy Of Prematurity Therapeutics Market Size by Application
7.3.1 Europe Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2027)
7.4 Europe Retinopathy Of Prematurity Therapeutics Market Size by Country
7.4.1 Europe Retinopathy Of Prematurity Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Retinopathy Of Prematurity Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Type
8.2.1 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Application
8.3.1 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region
8.4.1 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinopathy Of Prematurity Therapeutics Market Size (2016-2027)
9.2 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Type
9.2.1 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Application
9.3.1 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country
9.4.1 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Type
10.2.1 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Application
10.3.1 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country
10.4.1 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biomar Microbial Technologies
11.1.1 Biomar Microbial Technologies Company Details
11.1.2 Biomar Microbial Technologies Business Overview
11.1.3 Biomar Microbial Technologies Retinopathy Of Prematurity Therapeutics Introduction
11.1.4 Biomar Microbial Technologies Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
11.1.5 Biomar Microbial Technologies Recent Development
11.2 D. Western Therapeutics Institute Inc
11.2.1 D. Western Therapeutics Institute Inc Company Details
11.2.2 D. Western Therapeutics Institute Inc Business Overview
11.2.3 D. Western Therapeutics Institute Inc Retinopathy Of Prematurity Therapeutics Introduction
11.2.4 D. Western Therapeutics Institute Inc Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
11.2.5 D. Western Therapeutics Institute Inc Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Retinopathy Of Prematurity Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Insmed Inc
11.4.1 Insmed Inc Company Details
11.4.2 Insmed Inc Business Overview
11.4.3 Insmed Inc Retinopathy Of Prematurity Therapeutics Introduction
11.4.4 Insmed Inc Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
11.4.5 Insmed Inc Recent Development
11.5 Recordati SpA
11.5.1 Recordati SpA Company Details
11.5.2 Recordati SpA Business Overview
11.5.3 Recordati SpA Retinopathy Of Prematurity Therapeutics Introduction
11.5.4 Recordati SpA Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
11.5.5 Recordati SpA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of IB-09A0133
Table 3. Key Players of Mecasermin Rinfabate
Table 4. Key Players of Propranolol
Table 5. Key Players of R-200
Table 6. Key Players of Others
Table 7. Global Retinopathy Of Prematurity Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinopathy Of Prematurity Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Retinopathy Of Prematurity Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Retinopathy Of Prematurity Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Retinopathy Of Prematurity Therapeutics Market Share by Regions (2022-2027)
Table 13. Retinopathy Of Prematurity Therapeutics Market Trends
Table 14. Retinopathy Of Prematurity Therapeutics Market Drivers
Table 15. Retinopathy Of Prematurity Therapeutics Market Challenges
Table 16. Retinopathy Of Prematurity Therapeutics Market Restraints
Table 17. Global Retinopathy Of Prematurity Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Retinopathy Of Prematurity Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Retinopathy Of Prematurity Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinopathy Of Prematurity Therapeutics as of 2020)
Table 20. Ranking of Global Top Retinopathy Of Prematurity Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Retinopathy Of Prematurity Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinopathy Of Prematurity Therapeutics Product Solution and Service
Table 24. Date of Enter into Retinopathy Of Prematurity Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Retinopathy Of Prematurity Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Retinopathy Of Prematurity Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Retinopathy Of Prematurity Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Retinopathy Of Prematurity Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Retinopathy Of Prematurity Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Biomar Microbial Technologies Company Details
Table 65. Biomar Microbial Technologies Business Overview
Table 66. Biomar Microbial Technologies Retinopathy Of Prematurity Therapeutics Product
Table 67. Biomar Microbial Technologies Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Biomar Microbial Technologies Recent Development
Table 69. D. Western Therapeutics Institute Inc Company Details
Table 70. D. Western Therapeutics Institute Inc Business Overview
Table 71. D. Western Therapeutics Institute Inc Retinopathy Of Prematurity Therapeutics Product
Table 72. D. Western Therapeutics Institute Inc Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021) & (US$ Million)
Table 73. D. Western Therapeutics Institute Inc Recent Development
Table 74. F. Hoffmann-La Roche Ltd Company Details
Table 75. F. Hoffmann-La Roche Ltd Business Overview
Table 76. F. Hoffmann-La Roche Ltd Retinopathy Of Prematurity Therapeutics Product
Table 77. F. Hoffmann-La Roche Ltd Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021) & (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd Recent Development
Table 79. Insmed Inc Company Details
Table 80. Insmed Inc Business Overview
Table 81. Insmed Inc Retinopathy Of Prematurity Therapeutics Product
Table 82. Insmed Inc Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Insmed Inc Recent Development
Table 84. Recordati SpA Company Details
Table 85. Recordati SpA Business Overview
Table 86. Recordati SpA Retinopathy Of Prematurity Therapeutics Product
Table 87. Recordati SpA Revenue in Retinopathy Of Prematurity Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Recordati SpA Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinopathy Of Prematurity Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. IB-09A0133 Features
Figure 3. Mecasermin Rinfabate Features
Figure 4. Propranolol Features
Figure 5. R-200 Features
Figure 6. Others Features
Figure 7. Global Retinopathy Of Prematurity Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Home Care Case Studies
Figure 11. Retinopathy Of Prematurity Therapeutics Report Years Considered
Figure 12. Global Retinopathy Of Prematurity Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Retinopathy Of Prematurity Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Retinopathy Of Prematurity Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Retinopathy Of Prematurity Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Retinopathy Of Prematurity Therapeutics Market Share by Players in 2020
Figure 17. Global Top Retinopathy Of Prematurity Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinopathy Of Prematurity Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Retinopathy Of Prematurity Therapeutics Revenue in 2020
Figure 19. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Retinopathy Of Prematurity Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Retinopathy Of Prematurity Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Retinopathy Of Prematurity Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Retinopathy Of Prematurity Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Retinopathy Of Prematurity Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Retinopathy Of Prematurity Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Share by Region (2016-2027)
Figure 41. China Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Retinopathy Of Prematurity Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Retinopathy Of Prematurity Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Retinopathy Of Prematurity Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Biomar Microbial Technologies Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
Figure 61. D. Western Therapeutics Institute Inc Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
Figure 63. Insmed Inc Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
Figure 64. Recordati SpA Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---